Cargando…

Novel chemoimmunotherapeutic strategy for hepatocellular carcinoma based on a genome-wide association study

Pharmacotherapeutic options are limited for hepatocellular carcinoma (HCC). Recently, we identified the anti-tumor ligand MHC class I polypeptide-related sequence A (MICA) gene as a susceptibility gene for hepatitis C virus-induced HCC in a genome-wide association study (GWAS). To prove the concept...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goto, Kaku, Annan, Dorcas A., Morita, Tomoko, Li, Wenwen, Muroyama, Ryosuke, Matsubara, Yasuo, Ito, Sayaka, Nakagawa, Ryo, Tanoue, Yasushi, Jinushi, Masahisa, Kato, Naoya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133582/ https://www.ncbi.nlm.nih.gov/pubmed/27910927 http://dx.doi.org/10.1038/srep38407

Ejemplares similares

The Characteristic Changes in Hepatitis B Virus X Region for Hepatocellular Carcinoma: A Comprehensive Analysis Based on Global Data
por: Li, Wenwen, et al.
Publicado: (2015)

Cell death-induced immunogenicity enhances chemoimmunotherapeutic response by converting immune-excluded into T-cell inflamed bladder tumors
por: Nikolos, Fotis, et al.
Publicado: (2022)

Re-analysis of hepatitis B virus integration sites reveals potential new loci associated with oncogenesis in hepatocellular carcinoma
por: Kojima, Ryuta, et al.
Publicado: (2023)

Anti-hepatocellular carcinoma properties of the anti-alcoholism drug disulfiram discovered to enzymatically inhibit the AMPK-related kinase SNARK in vitro
por: Goto, Kaku, et al.
Publicado: (2016)

Leukotriene receptor antagonists enhance HCC treatment efficacy by inhibiting ADAMs and suppressing MICA shedding
por: Arai, Jun, et al.
Publicado: (2020)

Novel therapeutic features of disulfiram against hepatocellular carcinoma cells with inhibitory effects on a disintegrin and metalloproteinase 10
por: Goto, Kaku, et al.
Publicado: (2018)

Baseline soluble MICA levels act as a predictive biomarker for the efficacy of regorafenib treatment in colorectal cancer
por: Arai, Jun, et al.
Publicado: (2022)

Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma
por: Maeda, Takahiro, et al.
Publicado: (2019)

A Novel Role of Interleukin 13 Receptor alpha2 in Perineural Invasion and its Association with Poor Prognosis of Patients with Pancreatic Ductal Adenocarcinoma †
por: Fujisawa, Toshio, et al.
Publicado: (2020)

The role of innate immune signals in antitumor immunity
por: Jinushi, Masahisa
Publicado: (2012)

Chronic activation of DNA damage signals causes tumor immune evasion in the chemoresistant niche
por: Jinushi, Masahisa
Publicado: (2012)

Regulatory mechanisms of nucleic acid-mediated innate immune responses in the tumor microenvironment
por: Jinushi, Masahisa
Publicado: (2012)

Role of cancer stem cell-associated inflammation in creating pro-inflammatory tumorigenic microenvironments
por: Jinushi, Masahisa
Publicado: (2014)

Autophagy-dependent regulation of tumor metastasis by myeloid cells
por: Jinushi, Masahisa, et al.
Publicado: (2017)

Interferon-γ induced PD-L1 expression and soluble PD-L1 production in gastric cancer
por: Imai, Yushi, et al.
Publicado: (2020)

Serum Angiopoietin 2 acts as a diagnostic and prognostic biomarker in hepatocellular carcinoma
por: Ao, Junjie, et al.
Publicado: (2021)

Exploring microsatellite instability in patients with advanced hepatocellular carcinoma and its tumor microenvironment
por: Mukai, Shohei, et al.
Publicado: (2021)

T cell immunoglobulin domain and mucin domain-3 as an emerging target for immunotherapy in cancer management
por: Yoneda, Akihiro, et al.
Publicado: (2013)

The impact of FGF19/FGFR4 signaling inhibition in antitumor activity of multi-kinase inhibitors in hepatocellular carcinoma
por: Kanzaki, Hiroaki, et al.
Publicado: (2021)

Use of ramucirumab for various treatment lines in real-world practice of patients with advanced hepatocellular carcinoma
por: Kanogawa, Naoya, et al.
Publicado: (2023)

Effect of Atezolizumab plus Bevacizumab in Patients with Hepatocellular Carcinoma Harboring CTNNB1 Mutation in Early Clinical Experience
por: Ogawa, Keita, et al.
Publicado: (2022)

Durvalumab with or without tremelimumab combined with particle therapy for advanced hepatocellular carcinoma with macrovascular invasion: protocol for the DEPARTURE phase Ib trial
por: Ogasawara, Sadahisa, et al.
Publicado: (2022)

EZH1/2 inhibition augments the anti-tumor effects of sorafenib in hepatocellular carcinoma
por: Kusakabe, Yuko, et al.
Publicado: (2021)

Cross-talks of tumor and myeloid cells regulate the therapeutic responses to chemotherapy by modulating innate immune responses
por: Jinushi, Masahisa, et al.
Publicado: (2013)

Clinical significance of macrophage heterogeneity in human malignant tumors
por: Komohara, Yoshihiro, et al.
Publicado: (2014)

Hyperprogressive disease during atezolizumab plus bevacizumab treatment in patients with advanced hepatocellular carcinoma from Japanese real-world practice
por: Yumita, Sae, et al.
Publicado: (2023)

The RNA-Binding Protein ELAVL1 Regulates Hepatitis B Virus Replication and Growth of Hepatocellular Carcinoma Cells
por: Kanzaki, Hiroaki, et al.
Publicado: (2022)

Nurse-led group cognitive behavioral therapy for major depressive disorder among adults in Japan: A preliminary single-group study
por: Tanoue, Hiroki, et al.
Publicado: (2018)

Real‐world treatment patterns and clinical outcomes of Japanese patients with non‐muscle invasive bladder cancer receiving intravesical bacillus Calmette–Guérin treatment
por: Miyake, Makito, et al.
Publicado: (2022)

Antiviral Compounds Screening Targeting HBx Protein of the Hepatitis B Virus
por: Ma, Yaojia, et al.
Publicado: (2022)

MFG-E8 Regulates the Immunogenic Potential of Dendritic Cells Primed with Necrotic Cell-Mediated Inflammatory Signals
por: Baghdadi, Muhammad, et al.
Publicado: (2012)

Epstein-Barr Virus (EBV)-associated Gastric Carcinoma
por: Iizasa, Hisashi, et al.
Publicado: (2012)

Soluble MICA and a MICA Variation as Possible Prognostic Biomarkers for HBV-Induced Hepatocellular Carcinoma
por: Kumar, Vinod, et al.
Publicado: (2012)

Varicella Reinfection with Unilateral Varicella Pneumonia
por: Ariyasu, Ryo, et al.
Publicado: (2016)

Successful Treatment with Alectinib for Choroidal Metastasis in Anaplastic Lymphoma Kinase Rearranged Non-small Cell Lung Cancer
por: Funazo, Tomoko, et al.
Publicado: (2017)

Low expression levels of microRNA-124-5p correlated with poor prognosis in colorectal cancer via targeting of SMC4
por: Jinushi, Takafumi, et al.
Publicado: (2014)

Survival outcomes after stereotactic body radiotherapy for 79 Japanese patients with hepatocellular carcinoma
por: Yamashita, Hideomi, et al.
Publicado: (2015)

Scientific works of Masami Nakagawa
por: Nakagawa, Masami, et al.
Publicado: (2001)

Real World Treatment Practices for Mantle Cell Lymphoma in Japan: An Observational Database Research Study (CLIMBER-DBR)
por: Izutsu, Koji, et al.
Publicado: (2021)

Real World Treatment Practices for Chronic Lymphocytic Leukemia in Japan: An Observational Database Research Study (CLIMBER-DBR)
por: Takizawa, Jun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p5upjh7frf10jhk92ikjc2ru8u